Table 3 OARs, EARs, and AERs of subsequent LBCs after other cancers.

From: The burdens of lung cancer involved multiple primary cancers and its occurring patterns–SEER Analysis between 1973 and 2006

 

Subsequent LBC after other cancers in all patients

Subsequent LBC after other cancers in male patients

Subsequent LBC after other cancers in female patients

Absolute numbers

OARs

AERs

Absolute numbers

OARs

AERs

Absolute numbers

OARs

AERs

EARs

EARs

EARs

All cancers excluding LBC

56,479

27.90

2.73

34,263

37.86

2.94

22,216

19.84

2.55

25.17

34.92

17.29

Prostate

12,522

34.96

−9.07

12,522

34.96

−9.07

44.03

44.03

Breast

8,843

18.53

0

94

37.19

0

8,749

18.43

0

18.53

37.19

18.43

Colorectum

7,022

29.85

−0.39

4,325

37.45

−2.15

2,697

22.52

1.31

30.24

39.60

 

21.21

Urinary Bladder

6,419

59.63

24.76

5,101

63.48

24.13

1,318

48.28

26.61

34.87

39.35

21.67

Oral Cavity and Pharynx

3,995

75.15

49.49

2,918

84.05

53.67

1,077

58.40

41.63

25.66

30.38

16.77

Larynx

3,037

131.36

96.90

2,469

131.18

93.31

568

132.16

112.65

34.46

37.87

19.51

Non-Hodgkin Lymphoma

2,077

28.37

6.52

1,167

30.67

5.16

910

25.89

8.00

21.85

25.51

17.89

Corpus Uteri

1,916

15.78

−5.01

1,916

15.78

−5.01

20.79

20.79

Melanoma

1,665

13.58

−4.72

995

16.52

−7.51

670

10.75

−2.01

18.30

24.03

12.76

Kidney and Renal Pelvis

1,320

28.81

3.54

893

32.25

2.03

427

23.55

5.83

25.27

30.22

17.72

  1. Abbreviations: SPC, subsequent primary cancer; LBC, lung and bronchus cancer; OAR, observed annual risk; EAR, expected annual risk; AER, Annual excess risk.